Membership
Advancement to Fellow of SHEA
SHEA Journal Club
SHEA Spotlight
Careers
Education & Training
Online Education Center
Prevention CHKC
Guidance
Pocket Guidelines
Resources
Antimicrobial Stewardship
High-Consequence Pathogens
SARS-CoV-2 Resources
Advocacy
Action Center
Advocate Training & Resources
Emerging Legislation & Regulations
Priority Issues
Publications
Compendium
About
Board of Trustees
Committee Chairs
Strategic Plan
Diversity, Equity & Inclusion Pledge
Disclosure Policy
Twitter
Facebook
LinkedIn
News
MySHEA
SHEA Spring
SHEA Foundation
Donate
Join SHEA
Login
April 2023
The Costs of Inappropriate Outpatient Antibiotics
Phase 2 study of a Exeporfinium chloride (XF-73) gel, a novel agent for
S. aureus
nasal carriage reduction
Undisclosed: the role of aminopenicillins for the treatment of enterococcal UTIs despite
in vitro
resistance
Creation of a cumulative antibiogram for rapidly growing nontuberculous mycobacteria
Changing with the times: refining our mitigation strategies and policies as COVID evolves
We use cookies to help improve your experience
Ok
Enable JavaScript to ensure
website accessibility
